Promising drug for kids with rare blood diseases enters final testing phase
NCT ID NCT06512883
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This study tests a medicine called benralizumab in children aged 6 to 17 with two rare diseases that cause too many eosinophils (a type of white blood cell). The goal is to see if the drug is safe and helps control the disease. About 14 children will take part, and the study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAurora, Colorado, 80045, United States
-
Research Site
NOT_YET_RECRUITINGCincinnati, Ohio, 45229, United States
-
Research Site
RECRUITINGHighland Hills, Ohio, 44106-2624, United States
-
Research Site
RECRUITINGSão Paulo, 01232-010, Brazil
-
Research Site
RECRUITINGToronto, Ontario, M5G1X8, Canada
-
Research Site
NOT_YET_RECRUITINGLille, 59037, France
-
Research Site
NOT_YET_RECRUITINGMontpellier, 34295, France
-
Research Site
NOT_YET_RECRUITINGAhmedabad, 380013, India
-
Research Site
NOT_YET_RECRUITINGPetah Tikva, 49202, Israel
-
Research Site
RECRUITINGGuadalajara, 44620, Mexico
-
Research Site
NOT_YET_RECRUITINGRotterdam, 3015 GD, Netherlands
-
Research Site
NOT_YET_RECRUITINGKielce, 25-734, Poland
-
Research Site
NOT_YET_RECRUITINGWarsaw, 04-730, Poland
-
Research Site
RECRUITINGAltındağ, 06230, Turkey (Türkiye)
-
Research Site
RECRUITINGIstanbul, 34093, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.